Forschergruppe Diabetes e.V., Munich, Ingolstaedter Landstrasse 1, Neuherberg, 85764, Munich, Germany.
Internal Medicine Department, Clinical County Emergency Hospital Constanta, Tomis Blvd. No. 145, 900591, Constanta, Romania.
Cardiovasc Diabetol. 2018 Feb 19;17(1):30. doi: 10.1186/s12933-018-0667-2.
The 3rd Cardiovascular Outcome Trial Summit of the Diabetes & Cardiovascular Disease EASD Study Group was held on the 26-27 October 2017 in Munich. As in 2015 and 2016, this summit was organised in light of recently completed and published CVOTs on diabetes, aiming to serve as a reference meeting for in-depth discussions on the topic. Amongst others, the CVOTs EXSCEL, DEVOTE, the CANVAS program and the ACE-trial, which released primary outcome results in 2017, were discussed. Trial implications for diabetes management and recent perspectives of diabetologists, cardiologists, endocrinologists, nephrologists and general practitioners were highlighted. The clinical relevance of cardiovascular outcome trials and its implications regarding reimbursement were compared with real-world studies. The 4th Cardiovascular Outcome Trial Summit will be held in Munich 25-26 October 2018 ( http://www.dcvd.org ).
第三届糖尿病与心血管疾病 EASD 研究组心血管结局试验峰会于 2017 年 10 月 26 日至 27 日在慕尼黑举行。与 2015 年和 2016 年一样，本次峰会是根据最近完成并发表的糖尿病心血管结局试验组织召开的，旨在为深入讨论该主题提供参考。其中讨论了 EXSCEL、DEVOTE、CANVAS 计划和 ACE 试验，这些试验在 2017 年公布了主要结局结果。还强调了试验对糖尿病管理的影响以及糖尿病专家、心脏病专家、内分泌专家、肾病专家和全科医生的最新观点。心血管结局试验的临床相关性及其与实际研究相比的报销意义进行了比较。第四届心血管结局试验峰会将于 2018 年 10 月 25 日至 26 日在慕尼黑举行（http://www.dcvd.org）。
